Krka, d.d., Novo mesto formally notified The European Medicines Agency after deciding to withdraw their application for the centralized marketing authorization for Desloratadine Krka...
It's been tough to identify the problems that only turn up after medicines are on the market. An experimental project is now combing through data to get earlier, more accurate warnings.
Learn what the AMA is doing to address the administrative burdens, care delays and patient harms related to prior authorization.
Are you looking to pitch your story to Modern Healthcare? You maximize your chances of getting your story in front of the right person by sending press releases and inquiries to the reporter whose beat includes your subject area. This is especially true for features and trend stories or if you're looking to promote particular experts within your organization.
Doctors say that delays are hurting patient outcomes.
As a medical oncologist with a full-time practice, I deal with treatment delays and other consequences of prior authorization every day. And physicians across the nation believe the problem is getting worse.
Prior authorizations remain among the most vexing problems facing primary care practices
Patients and physicians tell their tales from the front about how prior authorization hampers care by delaying treatment.
An AMA survey details how much physician and staff time is gobbled up dealing with payer-required administrative tasks. See how your experience stacks up.
Prior authorization gobbles up valuable physician time and delays access to care. Learn from AMA experts about promising efforts to change things.
‘They want me to take my own system down. I’m not sick. I don’t need drugs’
From depression, anxiety and PTSD to migraines, chronic pain management and Alzheimer’s disease, VR is starting to show promise as a treatment.
Neither my anonymous source nor I knew the depth of the rabbit hole I was entering, or what it would reveal about health care costs in America.
Expensive branded drugs, diagnostic testing and imaging for some patients prior to low-risk surgery and population-based vitamin D screening all make the list.
In the second of a two-part series, we explore how patients can affect drug pricing strategies, even if they can't leave home.
Sometimes it is hard for hospitals to provide expensive care to poor patients.
People will do or pay almost anything to lessen their physical pain. Sometimes even going above the law to do so. But what ... Drug Crimes
We are seeing ever-increasing efforts to make us believe that lowering our cholesterol is always going to be a risk-free… Read More »
By offshoring its drug and medical supply manufacturing, the US has put patients and hospitals in a frighteningly precarious position.